Medications

Drug may boost vaccine responses in older adults

A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows.

Diseases, Conditions, Syndromes

Cirrhosis cases rising among women in North America

(HealthDay)—Cirrhosis disease burden in women has increased substantially since 2000, according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, ...

Medications

Glecaprevir and pibrentasvir aid HCV-positive kidney transplants

(HealthDay)—By treating or preventing infection, glecaprevir and pibrentasvir (G/P) regimens are promising for increasing access to the transplantation of kidneys from hepatitis C virus (HCV)-positive donors to HCV-negative ...

HIV & AIDS

Updated guidance for healthcare workers with HIV, hepatitis

In light of the low rate of transmission and advances in treatments for hepatitis B, hepatitis C, and HIV, the Society for Healthcare Epidemiology of America today released updated guidance for healthcare personnel living ...

Diseases, Conditions, Syndromes

Hepatitis C: silent killer

A trio of researchers were awarded the Nobel Medicine Prize on Monday for their discovery of the Hepatitis C virus, paving the way for blood tests and new treatments.

page 1 from 39

Hepatitis C virus

Hepatitis C virus (HCV) is a small (55-65 nm in size), enveloped, positive sense single strand RNA virus in the family Flaviviridae. Although Hepatitis A virus, Hepatitis B virus, and Hepatitis C virus have similar names (because they all cause liver inflammation), these are distinctly different viruses both genetically and clinically.

This text uses material from Wikipedia, licensed under CC BY-SA